How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Calcium Phosphate Bone Cement Market
- By Product Type: Hydroxyapatite-based Calcium Phosphate Cement, Tricalcium Phosphate-based Cement, Dicalcium Phosphate Dihydrate Cement, Brushite-based Cement, Calcium Phosphate Cement with Polymer Additives
- By Application: Orthopedic Surgery, Dental Surgery, Spinal Surgery, Craniofacial Surgery, Trauma Surgery
- By Formulation: Powder-Liquid Formulation, Premixed Injectable Paste, Self-setting Injectable Cement, Granules and Putty Formulations
- By End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Surgical Centers, Research and Academic Institutes
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hydroxyapatite-based Calcium Phosphate Cement leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 17 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Calcium Phosphate Bone Cement Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Application 5
Formulation 4
End User 5
Companies profiled
Stryker Corporation
Zimmer Biomet Holdings Inc.
DePuy Synthes (Johnson & Johnson)
Medtronic plc
B. Braun Melsungen AG
Wright Medical Group N.V. (a part of Stryker)
Heraeus Holding GmbH
Orthovita
Inc. (a Stryker company)
BioMimetic Therapeutics Inc.
Cortec GmbH
Medtronic
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →DePuy Synthes (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Wright Medical Group N.V. (a part of Stryker)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Heraeus Holding GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Orthovita
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Inc. (a Stryker company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BioMimetic Therapeutics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cortec GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medtronic
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Sino Biopharmaceutical Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Heraeus Medical GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Baxter International Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Arthrex
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,554M by 2033 · 6.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hydroxyapatite-based Calcium Phosphate Cement44.4
- Tricalcium Phosphate-based Cement7.7
- Dicalcium Phosphate Dihydrate Cement19.3
- Brushite-based Cement9.1
- Calcium Phosphate Cement with Polymer Additives19.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,312M → $2,264M · 7.1%
Europe$914.7M → $1,595M · 7.2%
Asia Pacific$835.1M → $1,418M · 6.8%
Latin America$517.0M → $834.4M · 6.2%
Middle East and Africa$397.7M → $722.9M · 7.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.392026
6.422027
6.422028
6.442029
6.442030
6.472031
6.472032
6.482033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Stryker Corporation10.7
- Zimmer Biomet Holdings Inc.29.9
- DePuy Synthes (Johnson & Johnson)6.8
- Medtronic plc5.5
- B. Braun Melsungen AG9.7
- Wright Medical Group N.V. (a part of Stryker)9.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type20.9%
Application27.8%
Formulation21.2%
End User30.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.1
- Europe23.3
- Asia Pacific20.7
- Latin America12.2
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Stryker Corporation | 87 | 74 | 96 | 91 | 88 | 74 | 85 |
| Zimmer Biomet Holdings Inc. | 82 | 90 | 86 | 92 | 75 | 92 | 86 |
| DePuy Synthes (Johnson & Johnson) | 69 | 82 | 69 | 70 | 71 | 83 | 74 |
| Medtronic plc | 77 | 79 | 80 | 62 | 68 | 61 | 71 |
| B. Braun Melsungen AG | 63 | 56 | 68 | 59 | 66 | 51 | 61 |
| Wright Medical Group N.V. (a part of Stryker) | 57 | 63 | 52 | 54 | 63 | 49 | 56 |
| Heraeus Holding GmbH | 41 | 53 | 56 | 58 | 60 | 42 | 52 |
| Orthovita | 56 | 47 | 58 | 43 | 35 | 48 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- DePuy Synthes (Johnson & Johnson)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Stryker Corporation | ✓ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Zimmer Biomet Holdings Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| DePuy Synthes (Johnson & Johnson) | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Medtronic plc | ✓ | ◐ | ◐ | − | ◐ | − |
| B. Braun Melsungen AG | − | − | ◐ | − | − | − |
| Wright Medical Group N.V. (a part of Stryker) | ◐ | ✓ | − | − | ◐ | ◐ |
| Heraeus Holding GmbH | − | ◐ | − | ◐ | ◐ | − |
| Orthovita | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Zimmer Biomet Holdings Inc.86
2Stryker Corporation85
3DePuy Synthes (Johnson & Johnson)74
4Medtronic plc71
5B. Braun Melsungen AG61
6Wright Medical Group N.V. (a part of Stryker)56
7Heraeus Holding GmbH52
8Orthovita48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Stryker CorporationZimmer Biomet Holdings Inc.
Challenger2
Strong scale, closing on the leaders.
DePuy Synthes (Johnson & Johnson)Medtronic plc
Contender1
Focused players with pockets of strength.
B. Braun Melsungen AG
Niche3
Specialists in a single segment or region.
Wright Medical Group N.V. (a part of Stryker)Heraeus Holding GmbHOrthovita
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Calcium Phosphate Bone Cement Market — a $438M beachhead inside a $7.39B market.
Beachhead (SOM)$438Mobtainable near-term
Serviceable (SAM)$2.60Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Hydroxyapatite-based Calcium Phosphate Cement
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Tricalcium Phosphate-based Cement
Strong fit — clear ROI and a fast path to value.
End user69 fit
Dicalcium Phosphate Dihydrate Cement
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Formulation
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Calcium Phosphate Bone Cement Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation11%
Closed-won7%
$20.5KCAC
$102KLTV
5.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Calcium Phosphate Bone Cement Market is a durable-growth opportunity — $6.39B by 2033, compounding at 8.6%.
TAM · 2025$3.29Btoday
TAM · 2033$6.39Bforecast
CAGR8.6%2027–2033
Cumulative$42.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.39BTotal addressable market
SAM$2.55BServiceable available market
SOM$475MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.39BLarge & growingTAM by 2033 at 8.6% CAGR
$2.55BServiceable nowreachable with today’s model
$475MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.98BBear5.6% CAGR
$6.39BBase8.6% CAGR
$8.17BBull11.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Calcium Phosphate Bone Cement Market — a $2.26B market by 2033. Plan: grow share from 11.0% to 18.4%.
Market size · 2033$2.26Btotal addressable
Market CAGR11.2%2027–2033
Target share18.4%from 11.0% today
Revenue ambition$416Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.0% | 18.4% | Ahead |
| Revenue | $270M | $416M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 33.1% | 42.4% | Behind |
| Customer retention | 87.1% | 94.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $42M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Calcium Phosphate Bone Cement Market conversation — a $8.67B market you can size, segment and defend in minutes.
Market size · 2033$8.67Btotal opportunity
Growth6.6%CAGR to 2033
Addressable buyers1,160+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 4 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Stryker CorporationZimmer Biomet Holdings Inc.DePuy Synthes (Johnson & Johnson)Medtronic plcB. Braun Melsungen AGWright Medical Group N.V. (a part of Stryker)Heraeus Holding GmbHOrthovita+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Calcium Phosphate Bone Cement Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Calcium Phosphate Bone Cement Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Laser Eye Shield Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportLaparoscopic Staplers Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportInsufflation Needles Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportHydroxyurea Market
Hydroxyurea Market is valued at USD 540 Million in 2025 and is expected to reach USD 695 Millio…
$540M market · 2025 base year
View reportHigh Potential Therapeutic Apparatus Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportHaemostat Market
Market size, share, segmentation and regional forecast.
$461M market · 2025 base year
View reportGutta percha Root Canal Obturator Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPeroxisome Proliferator Activated Receptor Delta Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportFluorescent Podoscopes Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportEnema Syringe Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportElectric Medical Bathtub Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportDigital X-ray Machine Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.